Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

FLIP Antikörper (AA 1-480) (Biotin)

Der Maus Monoklonal anti-FLIP Antikörper wird verwendet zum Nachweis von FLIP in Proben von Human. Er wurde validiert für WB, IHC und ICC.
Produktnummer ABIN2745531
442,31 €
Zzgl. Versandkosten 20,00 € und MwSt
50 μg
Lieferung nach: Deutschland
Lieferung in 2 bis 5 Werktagen

Kurzübersicht für FLIP Antikörper (AA 1-480) (Biotin) (ABIN2745531)

Target

Alle FLIP (CFLAR) Antikörper anzeigen
FLIP (CFLAR) (CASP8 and FADD-Like Apoptosis Regulator (CFLAR))

Reaktivität

  • 116
  • 36
  • 22
  • 2
  • 2
  • 2
  • 1
  • 1
Human

Wirt

  • 107
  • 15
  • 2
Maus

Klonalität

  • 109
  • 15
Monoklonal

Konjugat

  • 61
  • 6
  • 5
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser FLIP Antikörper ist konjugiert mit Biotin

Applikation

  • 103
  • 40
  • 28
  • 27
  • 27
  • 25
  • 21
  • 17
  • 12
  • 10
  • 9
  • 5
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC)

Klon

NF6
  • Bindungsspezifität

    • 16
    • 15
    • 15
    • 14
    • 9
    • 8
    • 8
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-480

    Verwendungszweck

    anti-FLIP (human), mAb (NF6) (Biotin)

    Spezifität

    Recognizes short (FLIPS) and long (FLIPL) splice variants of human FLIP. This antibody recognizes an epitope in the N-terminal DED region (aa1-194).

    Produktmerkmale

    Monoclonal Antibody. Recognizes short (FLIPS) and long (FLIPL) splice variants of human FLIP. This antibody recognizes an epitope in the N-terminal DED region (aa1-194). Isotype: Mouse IgG1. Clone: NF6. Applications: ICC, IHC, WB. Liquid. In PBS containing 10 % glycerol and 0.02 % sodium azide. FLIP is an apoptosis regulator protein which functions as a crucial link between cell survival and cell death pathways in mammalian cells and acts as an inhibitor of TNFRSF6 mediated apoptosis. A proteolytic fragment (p43) is likely retained in the death-inducing signaling complex (DISC) thereby blocking further recruitment and processing of caspase-8 at the complex. Full length and shorter isoforms have been shown either to induce apoptosis or to reduce TNFRSF-triggered apoptosis. FLIP lacks enzymatic (caspase) activity. FLIP is highly expressed in skeletal muscle, pancreas, heart, kidney, placenta and peripheral blood leukocytes.

    Immunogen

    Recombinant human FLIP (aa 1-480).

    Isotyp

    IgG1
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1 mg/mL

    Buffer

    In PBS containing 10 % glycerol and 0.02 % sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    Avoid freeze/thaw cycles.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    +4°C

    -20°C

    Stable for at least 1 year after receipt when stored at -20°C.

    Haltbarkeit

    12 months
  • Target

    FLIP (CFLAR) (CASP8 and FADD-Like Apoptosis Regulator (CFLAR))

    Andere Bezeichnung

    FLIP

    Hintergrund

    Alternate Names/Synonyms: I-FLICE, CLARP, CASPER, Usurpin, CASH, FLAME-1

    Product Description: FLIP is an apoptosis regulator protein which functions as a crucial link between cell survival and cell death pathways in mammalian cells and acts as an inhibitor of TNFRSF6 mediated apoptosis. A proteolytic fragment (p43) is likely retained in the death-inducing signaling complex (DISC) thereby blocking further recruitment and processing of caspase-8 at the complex. Full length and shorter isoforms have been shown either to induce apoptosis or to reduce TNFRSF-triggered apoptosis. FLIP lacks enzymatic (caspase) activity. FLIP is highly expressed in skeletal muscle, pancreas, heart, kidney, placenta and peripheral blood leukocytes.

    UniProt

    O15519

    Pathways

    Apoptose, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development
Sie sind hier:
Chat with us!